SV

Street Verdict

Analyst Scorecard

NIFTYPHARMA · NSE

Nifty Pharma

Index · View only — not on the trading terminal

₹28,386.9

+0.05% (+₹15.1)

Prev. close

₹28,371.8

Volume

1,66,12,248

As of

20 Nov 2026

Price history

Not enough intraday ticks yet — try again once trading is underway.

Analyst sentiment

Analysts lean bullish

5 analyst stances · last 90 days · one per analyst

Trackable

none in range

Long-Horizon

none in range

Commentary

5 · 5 bull / 0 neutral / 0 bear

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (5)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 99 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions
Showing the newest 100 of 154 opinionsShow 54 moreShow all

Index levels are informational only, not investment advice.

PPLPHARMA

Piramal Pharma Share Price Today Down 2.44%: What It Shows

Piramal Pharma shares fell to Rs 189.70, down 2.44% from the prior close of Rs 194.45, after opening near Rs 194.70 and reaching an intraday high of Rs 199.50. The decline occurs amid a large‑cap company reporting a P/B of 3.23x, negative ROE of 4.04% and EPS of Rs ‑2.36, figures that lag industry benchmarks.

2 days ago·Read at Univest
MANKIND

How JSW Steel, Dr Reddy’s, Mankind Pharma are fine-tuning AI investments

Mankind Pharma’s global CFO, Ashutosh Dhawan, highlighted the company’s AI strategy at the ETCFO Annual Conclave, stressing the need to balance immediate productivity gains with long‑term capability building. Dhawan noted that Mankind Pharma is prioritising AI projects that deliver measurable operational efficiencies while also investing in foundational data and compliance systems that may not show instant ROI. This dual approach aims to strengthen future competitiveness without compromising current financial discipline.

CIPLA

Cipla - IndiGo, Tata Motors PV among 10 Nifty stocks facing earnings downgrades

The Economic Times · 3 days ago

GLAND

Gland Pharma Holders Are Up 93% And Here Is What They Saw

Gland Pharma’s shares have risen about 93% year‑to‑date, reaching roughly ₹3,293 from ₹1,715 at the start of 2026. The rally follows a U.S. FDA approval for a methylprednisolone injectable, which helped lift quarterly revenue to ₹18.34 billion and improve net margin to 15.9%, prompting optimistic fair‑value estimates despite some analysts warning of capacity‑utilisation risks.

ALKEM

Alkem Labs shares fall 2% as US FDA issues warning letter to its Daman manufacturing facility

Upstox · 3 days ago

SUNPHARMA

Sun Pharmaceutical Industries Share Price Today Gains 2.17%

Univest · 3 days ago

PPLPHARMA

Piramal Pharma acquisition: Company to buy remaining 26% stake in Yapan Bio

BusinessLine · 4 days ago

CIPLA

Stocks for quick gains: Know target price, stop loss for GAIL, Tata Consumer and Cipla

Cipla shares have rebounded above key moving‑average support, with the RSI at 62.07 indicating growing buying pressure. Choice Broking’s analyst recommends buying at ₹1,417, setting a stop‑loss at ₹1,345 and targeting ₹1,560, which could yield roughly a 10.1% return if the bullish trend continues.

4 days ago·Read at News9live
SAILIFE

Sai Life Sciences rises 2.11% in Wednesday's session

Global Banking & Finance Review · 4 days ago

SAILIFE

Aragen Life Sciences Plans ₹1,500 Crore Expansion Investment

Voice of Healthcare · 4 days ago

ALKEM

Alkem Laboratories Q2 FY27 Earnings Call Key Highlights

Kalkine India · 5 days ago

GLENMARK

Glenmark Pharma shares rise over 2% as unit files US application for experimental solid-tumour drug

Moneycontrol.com · 5 days ago

GLAND

LINK PHARMA Share Price Today Up 11%

Gland Pharma shares rose about 80% over the past twelve months, making it one of the top gainers in the BSE Healthcare index. The surge contrasts with broader market trends, as the BSE Healthcare index gained 17.8% while the BSE Sensex fell 3.2% in the same period.

LAURUSLABS

Oyster Renewable Invests INR 372 Crore In 60.9 MW Wind-Solar Hybrid Project For Laurus Labs In Andhra Pradesh

SolarQuarter · 5 days ago

GLENMARK

Glenmark shares gain 2% to ₹2,673 after IND filing for first in class pentaspecific cancer antibody ISB 2301

Business Upturn · 5 days ago

LUPIN

Lupin: Nomura raises target price to Rs 2,780, sees nearly 40% upside as valuations turn attractive

Moneycontrol.com · 5 days ago

IPCALAB

Ipca Laboratories stock: Q2 profit rises as margins widen

ad-hoc-news.de · 5 days ago

LAURUSLABS

Laurus Labs rises 5.32% in Tuesday's session

Global Banking & Finance Review · 5 days ago

WOCKPHARMA

Pharma sector stocks today, November 17: Aarti Drugs jumps 1.60%, Wockhardt up 1.43%, Zydus Life rises 0.98%

Business Upturn · 6 days ago

DRREDDY

Dr. Reddy's Laboratories rallies Monday, outperforms competitors

MarketWatch · 6 days ago